Categories Analysis, Industrials

After mixed second quarter, what the future holds for KB Home (KBH)?

The management expects homebuilding revenues and selling prices to improve in the coming quarters

Last month, home construction in the US increased at the fastest pace in many years, exceeding expectations. The high demand and low inventory, mainly due to record-low home resales, bode well for homebuilders like KB Home (NYSE: KBH), which has remained resilient to recent challenges. The company maintained stable revenues and deliveries in recent quarters, aided by better conversion of unsold inventory and fewer cancellations.

The value of KB Home’s stock nearly doubled in the past nine months and mostly stayed above its long-term average this year. It traded at a multi-year high this week but lost momentum after the company reported mixed earnings for the second quarter. While there is a recovery in the cards, KBH is unlikely to go much higher this year from where it is now.

Buy KBH?

It might not be a good time to invest in the company now, but it would be a good idea to keep an eye on the stock given the underlying strength of the business. Also, the long-term outlook on the housing industry is healthy, while the demographics are favorable for KB Home’s business which mainly serves the first-time-buyer segment. Meanwhile, affordability will remain an issue for home buyers in the near future, due to softening spending power and elevated home prices. That is likely to dent the prospects of homebuilders to some extent.

KB Home Q2 2023 earnings infographic

Latest Data

In the second quarter, KB Home’s earnings and revenues beat estimated by a wide margin, which is the second beat in a row. Net income, however, declined in double digits to $1.94 per share, while the top line grew modestly to $1.77 billion helped by higher Homebuilding revenues. The weak bottom-line performance is mainly attributable to an unfavorable comparison with the year-ago quarter, which included a positive impact on the company’s mortgage banking joint venture. Though the average selling price declined 3% the management sees a recovery in the second half of the year, which in turn would enhance gross margins.  

From KB Home’s Q2 2023 earnings call:

“We continue to attract buyers above our targeted income levels with healthy credit, who can qualify at higher mortgage rates and make a significant down payment. During the quarter, we maintained our cautious approach to land investment, spending $81 million to acquire new land. While our divisions are diligently looking for land deals, we’re being disciplined in our underwriting with respect to achieving our required returns. We have the flexibility to remain selective given our current lot position and healthy balance sheet. With demand improving, we expect our land acquisition activity to accelerate during the second half of 2023.”

Guidance

The company issued positive full-year guidance, taking a cue from an uptick in orders and favorable backlog position. Housing revenue is expected to be in the range of $5.80 billion to $6.20 billion, and the average selling price is expected to be around $485,000. The guidance for housing gross profit margin is 21.2%, assuming no inventory-related charges, while SG&A expenses as a percentage of housing revenues are expected to be about 10.3%.

On Thursday, KBH opened sharply lower, extending the post-earnings weakness. It has grown 58% in the past six months.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025

For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model

Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer

Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third

Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance

Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top